Search result for 'generic medication'

Alkem Launches Generic Diabetes Drug Empanorm in India

March 12, 2025 12:33

Alkem Laboratories has launched a generic medication for type-2 diabetes, chronic kidney disease and heart failure in India under the brand name Empanorm, offering prices 80% lower than innovator...

Glenmark Recalls ADHD Medication in US: USFDA

March 2, 2025 11:44

Glenmark Pharmaceuticals is recalling 15 lakh bottles of Atomoxetine Capsules in the US due to an N-Nitroso Atomoxetine impurity above the FDA limit. The recall is classified as Class II, meaning...

Glenmark Launches Generic Glaucoma Treatment in US

February 14, 2025 09:32

Glenmark Pharmaceuticals launches a generic ophthalmic solution for glaucoma in the US market, adding to its growing portfolio of ophthalmic products.

Lupin Gets USFDA Nod for Generic HIV Drug

February 3, 2025 15:54

Lupin has received USFDA approval for its generic version of Symtuza, a medication for HIV. The product is estimated to have annual sales of USD 1.374 billion in the US.

Granules India Gets USFDA Nod for Generic ADHD Drug

December 17, 2024 15:50

Granules India's subsidiary receives USFDA approval for generic Lisdexamfetamine Dimesylate chewable tablets, a medication used to treat ADHD and binge eating disorder.

Cipla Recalls Generic Drug in US: Broken Tablets - FDA

November 20, 2024 17:21

Cipla is recalling over 1,800 boxes of Lanthanum Carbonate chewable tablets in the US due to reports of broken tablets. The recall, classified as Class II, affects the medication used for high...

Dr Reddy's & FDC Recall Products in US for Manufacturing Issues

November 17, 2024 11:25

Dr Reddy's Laboratories and FDC Ltd are recalling generic medications in the US due to manufacturing issues. The recall affects Morphine Sulfate extended-release tablets and Timolol Maleate...

Granules India Gets USFDA Nod for Generic Depression Drug

October 18, 2024 13:40

Granules India has received USFDA approval to market a generic medication for major depressive disorder, Bupropion Hydrochloride extended-release tablets USP (SR), expanding its presence in the US...

Glenmark Recalls Products in US for Manufacturing Issues

October 13, 2024 12:06

Glenmark Pharmaceuticals is recalling two products in the US, Ryaltris Nasal Spray and Ciclopirox Gel, due to manufacturing defects. The USFDA has classified the recalls as Class II and Class III.

Biocon Gets USFDA Approval for Generic Heart Failure Drug

September 1, 2024 19:14

Biocon's subsidiary receives USFDA approval for generic Sacubitril/Valsartan Tablets, a medication used to treat chronic heart failure in adults and children.

Zydus Lifesciences Gets USFDA Nod for Generic Parkinson's Drug

August 28, 2024 16:25

Zydus Lifesciences has received USFDA approval for Amantadine extended-release capsules, a generic medication for Parkinson's disease, providing 180 days of exclusivity.

Alembic Pharma Gets USFDA Nod for Scalp Psoriasis Drug

August 26, 2024 17:07

Alembic Pharmaceuticals has received USFDA approval to market a generic medication for treating moderate-to-severe scalp psoriasis. The drug, Betamethasone Valerate Foam, is therapeutically...

Glenmark Launches Generic Eye Itch Treatment in US

August 19, 2024 16:00

Glenmark Pharmaceuticals' US subsidiary has launched a generic eye itch treatment, Olopatadine Hydrochloride Ophthalmic Solution (OTC), addressing growing market demand.

Lupin Gets USFDA Approval for Generic Seizure Medication

July 12, 2024 17:31

Lupin has received USFDA approval to market a generic version of Topiramate extended-release capsules for the treatment of seizures in patients aged 6 and older.

Glenmark Gets USFDA Approval for Generic Nexium

June 12, 2024 10:57

Glenmark receives USFDA approval to market generic Esomeprazole Magnesium delayed-release capsules, a generic version of Nexium. This approval will allow the company to enter the market for...

Lupin Launches Generic Drugs in US: USFDA Approval

June 3, 2024 17:11

Lupin has received USFDA approval to launch generic Doxycycline for Injection and Letermovir Tablets in the US market, targeting a combined annual market value of USD 362 million.

Alembic Pharma Gets USFDA Nod for Heart Failure Drug

May 30, 2024 16:20

Alembic Pharmaceuticals receives USFDA approval to market a generic medication for heart failure, a therapeutically equivalent version of Novartis's Entresto tablets.

Strides Pharma Gets USFDA Nod for Generic Gastrointestinal Drug

May 22, 2024 15:19

Strides Pharma Science's unit receives USFDA approval to market a generic version of Sucralfate Oral Suspension, a medication used to treat gastrointestinal diseases.

Cipla Gets USFDA Nod for Generic Lanreotide Injection

May 22, 2024 12:13

Cipla receives USFDA approval to market generic Lanreotide injection, a treatment for acromegaly and other conditions. The drug is a therapeutic equivalent to Somatuline Depot Injection.

Zydus Lifesciences Gets USFDA Approval for Generic Arthritis Drug

May 11, 2024 16:27

Zydus Lifesciences receives USFDA approval to market Dexamethasone tablets (1mg) for arthritis, blood disorders, and other conditions in the US.

Dr Reddy's Launches Generic Anti-Bacterial Drug in US

May 3, 2024 16:11

Dr Reddy's Laboratories has launched a generic Doxycycline Capsules (40 mg) in the US market, a therapeutic equivalent of Oracea capsules (40 mg).

Lupin Gets USFDA Approval for Generic Eye Treatment Drug

April 25, 2024 19:55

Lupin receives USFDA approval to market Etabonate Ophthalmic Suspension, a generic treatment for seasonal allergic conjunctivitis. The drug is a generic equivalent of Bausch & Lomb's Lotemax.

Zydus Lifesciences Launches Generic Overactive Bladder Drug in US

April 22, 2024 11:30

Zydus Lifesciences has launched a generic medication for overactive bladder in the US market. The drug, Mirabegron, is expected to increase access and availability for patients.

Gland Pharma Gets USFDA Approval for Generic Breast Cancer Drug

April 8, 2024 16:47

Gland Pharma receives USFDA approval for Eribulin Mesylate Injection, a generic breast cancer drug, expected to be the first in the market. The company plans to launch the product soon.

Lupin Gets USFDA Nod for Generic Tardive Dyskinesia Drug

April 8, 2024 16:01

Lupin has received USFDA approval to market a generic medication for tardive dyskinesia, a movement disorder. The drug, Valbenazine Capsules, is a generic equivalent of Ingrezza Capsules and is...

Lupin Gets USFDA Nod for Generic Eye Medication

February 6, 2024 19:59

Lupin receives USFDA approval to market a generic medication for swelling and pain in the eye, a generic equivalent of Sun Pharma's BromSite Ophthalmic Solution.

Strides Pharma Gets USFDA Nod for Generic Pregabalin

January 25, 2024 20:20

Strides Pharma Science subsidiary receives USFDA approval for generic Pregabalin capsules, a medication for nerve pain. The product is bio-equivalent to Lyrica capsules and has a market size of USD...

Zydus Lifesciences Gets USFDA Approval for Generic Gabapentin

January 25, 2024 15:34

Zydus Lifesciences receives USFDA approval to market generic Gabapentin tablets for postherpetic neuralgia, marking the first company to receive final approval for this strength.

Lupin Launches Generic Postoperative Inflammation Drug in US

January 9, 2024 18:52

Lupin launches generic Bromfenac Ophthalmic Solution in the US, offering a cost-effective treatment for postoperative inflammation after cataract surgery.

Dr Reddy's Recalls Generic Drug in US Due to Packaging Error

January 7, 2024 10:27

Dr Reddy's Laboratories recalls over 8,000 bottles of Tacrolimus capsules in the US due to a packaging error, leading to the presence of foreign tablets/capsules in affected lots.

Lupin Gets USFDA Approval for Generic Diabetes Drug

January 4, 2024 19:17

Lupin receives USFDA approval to market a generic version of AstraZeneca's Qtern tablets, a medication for type 2 diabetes. The drug will be manufactured at Lupin's Pithampur facility.

Lupin Gets USFDA Approval for Generic Diabetes Drug

January 4, 2024 19:12

Lupin has received USFDA approval to market a generic medication for type 2 diabetes, a generic equivalent of AstraZeneca's Qtern tablets. The drug will be manufactured at Lupin's Pithampur facility.

Aurobindo Gets USFDA Nod for Generic Asthma Medication

November 30, 2023 14:54

Aurobindo Pharma's subsidiary receives USFDA approval to market a generic asthma medication, Budesonide Inhalation Suspension, for children aged 12 months to 8 years. The product is expected to...

Aurobindo Pharma Gets USFDA Approval for HIV Drug

November 29, 2023 12:54

Aurobindo Pharma receives USFDA approval to market a generic HIV-1 treatment drug, Darunavir tablets, in strengths of 600 mg and 800 mg. The drug is therapeutically equivalent to Prezista tablets.

Lupin Gets USFDA Approval for Generic Pulmonary Hypertension Drug

November 2, 2023 14:19

Lupin receives USFDA approval to market generic Selexipag for injection, a treatment for pulmonary arterial hypertension. The drug will be manufactured at the company's Nagpur facility.

Company Name
Price
Volume

Vodafone Idea L
8.19 ( -0.49)
57919628

AvanceTechnologies
0.64 ( 0.00)
25522388

Standard Capital
0.52 ( -3.70)
16619978

GTL Infrastructure
1.53 (+ 2.68)
15285011

YES Bank Ltd.
17.95 (+ 3.16)
12503288

MORE NEWS

Sebi Launches Document Verification System for Transparency

US Tariffs Impact Indian Exports: Shrimp, Carpets, Jewellery Face Challenges

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2025	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us

Search result for 'generic medication'

Alkem Launches Generic Diabetes Drug Empanorm in India

Glenmark Recalls ADHD Medication in US: USFDA

Glenmark Launches Generic Glaucoma Treatment in US

Lupin Gets USFDA Nod for Generic HIV Drug

Granules India Gets USFDA Nod for Generic ADHD Drug

Cipla Recalls Generic Drug in US: Broken Tablets - FDA

Dr Reddy's & FDC Recall Products in US for Manufacturing Issues

Granules India Gets USFDA Nod for Generic Depression Drug

Glenmark Recalls Products in US for Manufacturing Issues

Biocon Gets USFDA Approval for Generic Heart Failure Drug

Zydus Lifesciences Gets USFDA Nod for Generic Parkinson's Drug

Alembic Pharma Gets USFDA Nod for Scalp Psoriasis Drug

Glenmark Launches Generic Eye Itch Treatment in US

Lupin Gets USFDA Approval for Generic Seizure Medication

Glenmark Gets USFDA Approval for Generic Nexium

Lupin Launches Generic Drugs in US: USFDA Approval

Alembic Pharma Gets USFDA Nod for Heart Failure Drug

Strides Pharma Gets USFDA Nod for Generic Gastrointestinal Drug

Cipla Gets USFDA Nod for Generic Lanreotide Injection

Zydus Lifesciences Gets USFDA Approval for Generic Arthritis Drug

Dr Reddy's Launches Generic Anti-Bacterial Drug in US

Lupin Gets USFDA Approval for Generic Eye Treatment Drug

Zydus Lifesciences Launches Generic Overactive Bladder Drug in US

Gland Pharma Gets USFDA Approval for Generic Breast Cancer Drug

Lupin Gets USFDA Nod for Generic Tardive Dyskinesia Drug

Lupin Gets USFDA Nod for Generic Eye Medication

Strides Pharma Gets USFDA Nod for Generic Pregabalin

Zydus Lifesciences Gets USFDA Approval for Generic Gabapentin

Lupin Launches Generic Postoperative Inflammation Drug in US

Dr Reddy's Recalls Generic Drug in US Due to Packaging Error

Lupin Gets USFDA Approval for Generic Diabetes Drug

Lupin Gets USFDA Approval for Generic Diabetes Drug

Aurobindo Gets USFDA Nod for Generic Asthma Medication

Aurobindo Pharma Gets USFDA Approval for HIV Drug

Lupin Gets USFDA Approval for Generic Pulmonary Hypertension Drug

TODAY'S MOST TRADED COMPANIES

MORE NEWS

Moneywiz Live!

ALL MONEYWIZ PAGES